Associated Papers
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Flümann R et al.
Blood Cancer Discovery, 2023
36346827 (PubMed )
Supplement: bcd-22-0007_table_s6_suppst6.xlsx › F_Mut_Pat.__6
Characterization of the novel HLA-B*08:67:02N allele by next-generation sequencing.
Genebrier S et al.
Hla, 2021
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
Castro A et al.
Bmc Medical Genomics, 2019
31345234 (PubMed )
Supplement: 12920_2019_544_MOESM9_ESM.xlsx › Table_S2
Select a paper to view details